Published in Medical Letter on the CDC and FDA, February 28th, 2010
aggressive non-Hodgkin's lymphoma filed with the U.S. Food and Drug
Administration (the "FDA") and accepted for review in 2009. The FDA
established Prescription Drug User Fee Act (PDUFA) date of April 23,
2010. -- Initiated a Marketing Authorization Application ("MAA") for pixantrone
in Europe in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA